Inventor · disambiguated record
Donald Weaver
Also filed as: WEAVER DONALD · WEAVER DONALD F · WEAVER DONALD FREDRIC
25 granted patents·26 pending applications·919 citations·filing 1995–2023
97Inventor score
Top patents by PatentIndex Score
51 records- 0196US6930112B2Anti-epileptogenic agentsUNIV KINGSTON·Filed 2001·Granted Aug 16, 2005·78 cites·29 claims
- 0294US6562836B1Methods and compounds for inhibiting amyloid depositsUNIV KINGSTON·Filed 2000·Granted May 13, 2003·62 cites·172 claims
- 0394US5643562AMethod for treating amyloidosisUNIV KINGSTON·Filed 1995·Granted Jul 1, 1997·137 cites·55 claims
- 0491US5972328AMethod for treating amyloidosisUNIV KINGSTON·Filed 1995·Granted Oct 26, 1999·88 cites·58 claims
- 0591US5840294AMethod for treating amyloidosisUNIV KINGSTON·Filed 1995·Granted Nov 24, 1998·101 cites·66 claims
- 0690US5728375AMethod for treating amyloidosisUNIV KINGSTON·Filed 1995·Granted Mar 17, 1998·88 cites·71 claims
- 0787US6291247B1Methods of screening for factors that disrupt neurotrophin conformation and reduce neurotrophin biological activityUNIV KINGSTON·Filed 1997·Granted Sep 18, 2001·97 cites·18 claims
- 0884US5858326AMethods of increasing amyloid depositionNEUROCHEM INC·Filed 1995·Granted Jan 12, 1999·79 cites·5 claims
- 0980US7754761B2Sulfonated compounds and compositions for treating amyloidosisBELLUS HEALTH INT LTD·Filed 2007·Granted Jul 13, 2010·3 cites·5 claims
- 1079US7393875B2Methods and compounds for inhibiting amyloid depositsNEUROCHEM INT LTD·Filed 2003·Granted Jul 1, 2008·9 cites·9 claims
- 1178US7148352B2Method of inhibiting neurotrophin-receptor bindingUNIV KINGSTON·Filed 2002·Granted Dec 12, 2006·9 cites·19 claims
- 1278US6492380B1Method of inhibiting neurotrophin-receptor bindingUNIV KINGSTON·Filed 1999·Granted Dec 10, 2002·40 cites·18 claims
- 1377US6468990B1Method of inhibiting binding of nerve growth factor to p75 NTR receptorUNIV KINGSTON·Filed 2000·Granted Oct 22, 2002·9 cites·33 claims
- 1476US9339227B2Cognitive function assessment in a patientD ARCY RYAN·Filed 2011·Granted May 17, 2016·32 cites·11 claims
- 1575US7501429B2Pyrimidine compounds as anti-ictogenic and/or anti-epileptogenic agentsUNIV KINGSTON·Filed 2002·Granted Mar 10, 2009·12 cites·16 claims
- 1675US7153692B2Diagnostic methods for determining susceptibility to convulsive conditionsUNIV KINGSTON·Filed 2005·Granted Dec 26, 2006·6 cites·21 claims
- 1773US8835476B2Synthesis of novel antimicrobialsWU FAN·Filed 2006·Granted Sep 16, 2014·2 cites·10 claims
- 1873US7786174B2Methods and compounds for inhibiting amyloid depositsBELLUS HEALTH INT LTD·Filed 2008·Granted Aug 31, 2010·1 cites·9 claims
- 1973US2009215814A1Method of inhibiting neurotrophin-receptor bindingROSS GREGORY M·Filed 2009·Application pending·0 cites
- 2071US6029114AMolecular modelling of neurotrophin-receptor bindingUNIV KINGSTON·Filed 1997·Granted Feb 22, 2000·43 cites·18 claims
- 2170US2008221147A1Method of inhibiting neurotrophin-receptor bindingROSS GREGORY M·Filed 2008·Application pending·0 cites
- 2263US2006063793A1Method of inhibiting neurotrophin-receptor bindingROSS GREGORY M·Filed 2005·Application pending·0 cites
- 2361US2009099100A1Compositions and methods for treating amyloidosisBELLUS HEALTH INT LTD·Filed 2008·Application pending·0 cites
- 2460US8420640B2Methods of treating amyloid disease using analogs of 1-(4-nitrophenyl) piperazineBARDEN CHRISTOPHER J·Filed 2009·Granted Apr 16, 2013·1 cites·22 claims
- 2560US6417159B1Method of enhancing effect of a neurotrophin with analogues of p75NTR367-379.UNIV KINGSTON·Filed 1997·Granted Jul 9, 2002·22 cites·18 claims
- 2660US2023265079A1Inhibitor of indoleamine 2,3-dioxygenase-1 and methods of manufacture and use thereofUNIV HEALTH NETWORK·Filed 2023·Application pending·0 cites
- 2758US2003108595A1Method for treating amyloidosisUNIV KINGSTON·Filed 2002·Application pending·0 cites
- 2857US11568956B2Methods for identifying inhibitors of amyloid protein aggregationTREVENTIS CORP·Filed 2018·Granted Jan 31, 2023·0 cites·15 claims
- 2957US2007078137A1Method of inhibiting neurotrophin-receptor bindingROSS GREGORY M·Filed 2006·Application pending·0 cites
- 3057US2004208875A1Method for treating amyloidosisUNIV KINGSTON·Filed 2004·Application pending·0 cites
- 3156US2001048941A1Method for treating amyloidosisUNIV KINGSTON·Filed 2001·Application pending·0 cites
- 3254US11572354B2Inhibitor of indoleamine 2,3-dioxygenase-1 and methods of manufacture and use thereofUNIV HEALTH NETWORK·Filed 2019·Granted Feb 7, 2023·0 cites·8 claims
- 3353US2023145823A1Furosemide compositions and uses thereof for supportive therapy in coronavirus infectionUNIV HEALTH NETWORK·Filed 2021·Application pending·0 cites
- 3453US2004198832A1Compositions and methods for treating amyloidosisUNIV KINGSTON·Filed 2003·Application pending·0 cites
- 3552US2022259167A1Furosemide analogues and compositions and uses thereof for treatment of alzheimer's diseaseUNIV HEALTH NETWORK·Filed 2020·Application pending·0 cites
- 3652US2011002875A1Method for treating amyloidosisBELLUS HEALTH INTERNATIONAL LTD·Filed 2010·Application pending·0 cites
- 3751US2006167095A1Method for treating amyloidosisKISILEVSKY ROBERT·Filed 2005·Application pending·0 cites
- 3851US2011281951A1Compositions and methods for treating amyloidosisSZAREK WALTER·Filed 2011·Application pending·0 cites
- 3950US2003203923A1Method of inhibiting neurotrophin-receptor bindingFiled 2002·Application pending·0 cites
- 4049US8362066B2Compounds and methods for treating protein folding disordersTREVENTIS CORP·Filed 2007·Granted Jan 29, 2013·0 cites·6 claims
- 4147US2007042497A1Diagnostic methods for determining susceptibility to convulsive conditionsUNIV KINGSTON·Filed 2006·Application pending·0 cites
- 4245US12358902B25-(2,5-bis(4-chloro-2-isopropylphenyl)thiophen-3-yl)-1H-tetrazole for the topical treatment of bacterial infectionsDENOVAMED INC·Filed 2018·Granted Jul 15, 2025·0 cites·12 claims
- 4345US2007060606A1Compounds and methods for modulating phosphodiesterase 10AROBERTSON HAROLD A·Filed 2006·Application pending·0 cites
- 4444US2016283652A1Methods for identifying inhibitors of amyloid protein aggregationTREVENTIS CORP·Filed 2016·Application pending·0 cites
- 4543US2006014752A1Heterocyclic anti-epileptogenic agents and methods of use thereofUNIV KINGSTON·Filed 2005·Application pending·0 cites
- 4641US2003077833A1Diagnositc methods for determining susceptibility to convulsive conditionsUNIV KINGSTON·Filed 2002·Application pending·0 cites
- 4741US2003114441A1Heterocyclic anti-epileptogenic agents and methods of use thereofUNIV KINGSTON·Filed 2002·Application pending·0 cites
- 4837US2007015813A1Treatment of protein folding disordersUNIV KINGSTON·Filed 2006·Application pending·0 cites
- 4937US2010137388A1Therapeutic Pro-Antibiotic Agents and Methods of Use ThereofBARDEN CHRISTOPHER J·Filed 2008·Application pending·0 cites
- 5035US2014357725A1Terpene analogues and uses thereof for treating neurological conditionsWEAVER DONALD F·Filed 2012·Application pending·0 cites
Showing the top 50 of 51 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Donald Weaver files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →